A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease.
Schena FP, Esposito P, Rossini M.
Int J Mol Sci. 2020 Jan 14;21(2):525. doi: 10.3390/ijms21020525.
Membranoproliferative glomerulonephritis.
Alchi B, Jayne D.
Pediatr Nephrol. 2010 Aug;25(8):1409-18. doi: 10.1007/s00467-009-1322-7. Epub 2009 Nov 12.
Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy.
Kovala M, Seppälä M, Räisänen-Sokolowski A, Meri S, Honkanen E, Kaartinen K.
Cells. 2023 Feb 23;12(5):712. doi: 10.3390/cells12050712.
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F, Javaugue V, Nasr SH, Leung N.
Nephrol Dial Transplant. 2021 Jan 25;36(2):208-215. doi: 10.1093/ndt/gfz176.
Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
Noris M, Daina E, Remuzzi G.
Nephrol Dial Transplant. 2023 Feb 13;38(2):283-290. doi: 10.1093/ndt/gfab281.
Type I membranoproliferative glomerulonephritis and HCV infection.
Rostoker G, Pawlotsky JM, Bastie A, Weil B, Dhumeaux D.
Nephrol Dial Transplant. 1996;11 Suppl 4:22-4. doi: 10.1093/ndt/11.supp4.22.
Retinal findings in glomerulonephritis.
Mack HG, Colville DJ, Harraka P, Savige JA, Invernizzi A, Fraser-Bell S.
Clin Exp Optom. 2022 Jul;105(5):474-486. doi: 10.1080/08164622.2021.2003691. Epub 2021 Dec 8.
Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience.
Green H, Rahamimov R, Rozen-Zvi B, Pertzov B, Tobar A, Lichtenberg S, Gafter U, Mor E.
Transplantation. 2015 Jun;99(6):1172-7. doi: 10.1097/TP.0000000000000459.
Membranoproliferative Glomerulonephritis Type I Associated with Intravenous Immunoglobulin Administration Arising in a Child with X-Linked Agammaglobulinemia: A Case Report and a Reappraisal.
Hussein MRA, Babiker M, Asim S, Elsamwal M.
Saudi J Kidney Dis Transpl. 2023 Nov 1;34(6):660-665. doi: 10.4103/sjkdt.sjkdt_133_23. Epub 2024 May 9.
Rituximab therapy for Type I membranoproliferative glomerulonephritis.
Dillon JJ, Hladunewich M, Haley WE, Reich HN, Cattran DC, Fervenza FC.
Clin Nephrol. 2012 Apr;77(4):290-5. doi: 10.5414/cn107299.
